Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Bittner

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Circulation|July 11, 2012
Cardiac rehabilitation: call to action for healthcare providersVera Bittner
Circulation|August 5, 2024
Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease PreventionVera Bittner
Journal of Cardiovascular Risk|December 13, 2002
Women and coronary heart disease risk factorsVera Bittner
Circulation|November 30, 2016
Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?Vera Bittner
Current Opinion in Cardiology|October 21, 2006
Perspectives on dyslipidemia and coronary heart disease in women: an updateVera Bittner
Journal of the American College of Cardiology|May 16, 2006
Menopause and cardiovascular risk cause or consequence?Vera Bittner
Expert Opinion on Pharmacotherapy|July 1, 2009
Postmenopausal hormone therapy and the risk of cardiovascular diseaseVera Bittner
JACC. Heart Failure|July 16, 2014
Functional status and outcome after coronary artery bypass graftingVera Bittner
The American Journal of Cardiology|November 7, 2002
Lipoprotein abnormalities related to women's healthVera Bittner
Coronary Artery Disease|May 27, 2006
Cardiac rehabilitation as secondary prevention centerVera Bittner, Bonnie Sanderson
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Circulation|July 11, 2012
Cardiac rehabilitation: call to action for healthcare providersVera Bittner
Circulation|August 5, 2024
Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease PreventionVera Bittner
Journal of Cardiovascular Risk|December 13, 2002
Women and coronary heart disease risk factorsVera Bittner
Circulation|November 30, 2016
Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?Vera Bittner
Current Opinion in Cardiology|October 21, 2006
Perspectives on dyslipidemia and coronary heart disease in women: an updateVera Bittner
Journal of the American College of Cardiology|May 16, 2006
Menopause and cardiovascular risk cause or consequence?Vera Bittner
Expert Opinion on Pharmacotherapy|July 1, 2009
Postmenopausal hormone therapy and the risk of cardiovascular diseaseVera Bittner
JACC. Heart Failure|July 16, 2014
Functional status and outcome after coronary artery bypass graftingVera Bittner
The American Journal of Cardiology|November 7, 2002
Lipoprotein abnormalities related to women's healthVera Bittner
Coronary Artery Disease|May 27, 2006
Cardiac rehabilitation as secondary prevention centerVera Bittner, Bonnie Sanderson
Pageof 27